Effects of a Therapeutic Interchange Between Branded and Generic Inhaled Therapy on Chronic Obstructive Pulmonary Disease

Authors

Rucha B Acharya, Nova Southeastern UniversityFollow
Tina Joseph, Nova Southeastern UniversityFollow
Cynthia Moreau, Nova Southeastern UniversityFollow
Genevieve M. Hale, Nova Southeastern UniversityFollow
Alexandra Perez, Nova Southeastern UniversityFollow
Elaina Rosario, Nova Southeastern UniversityFollow

ISBN or ISSN

2639-9636

Publication Title

The Senior Care Pharmacist

Volume

36

Issue

12

Publication Date / Copyright Date

12-2021

First Page

687

Last Page

692

Publisher

American Society of Consultant Pharmacists (ASCP)

DOI Number

10.4140/tcp.n.2021.687

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Keywords

adrenergic beta-2 receptor agonists, bronchodilator agents, humans, nebulizers and vaporizers, pulmonary disease, chronic obstructive, retrospective studies

NSUWorks Citation

Acharya, Rucha B; Joseph, Tina; Moreau, Cynthia; Hale, Genevieve M.; Perez, Alexandra; and Rosario, Elaina, "Effects of a Therapeutic Interchange Between Branded and Generic Inhaled Therapy on Chronic Obstructive Pulmonary Disease" (2021). Faculty Articles. 391.
https://nsuworks.nova.edu/hpd_corx_facarticles/391